ARROWHEAD PHARMACEUTICALS, INC.: capex

Value{"amount": 10067360, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2019-10-01 – 2020-06-30
Statussuperseded
EntityARROWHEAD PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-20-036812 · Open the official SEC filing →
Retrieved: 2026-08-19T08:45:36.806619+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000879407/capex/2020-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/41c7467c-696c-4e94-857f-96e50a6c3f2b

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies